Is Selpercatinib available in China?

The original drug Selpercatinib has not yet been launched in China, nor has it been covered by medical insurance. This drug is not yet available for sale in domestic hospitals or pharmacies, so patients cannot yet purchase it. Serpatinib is a cancer drug used in patients whose cancer is caused by changes in a gene called RET. It can be used for adults with advanced non-small cell lung cancer who have not previously been treated with RET inhibitors, adults with advanced thyroid cancer who have been treated with the cancer drug sorafenib or Lenvatinib or both, and advanced medullary thyroid cancer in patients over 12 years old. Selpercatinibcontains the active substance selpercatinib.